Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre‐eclampsia in a low‐risk nulliparous patient population?

Abstract

Change in angiogenic biomarkers between first and early second trimester combined with clinical characteristics has strong utility for predicting early-onset pre-eclampsia.